Delivery Order SPE2DB22D2206-SPE2DB25FFU10

Award Date 2/24/25
Potential Completion Date 3/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,300 fixed-price delivery order is for the supply of ALBUTEIN 5% VIAL 250ML, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,442.70 Firm Fixed Price Delivery Order is for the supply of ALBUTEIN 5% VIAL 500ML, a medical product, with a completion date of November 19, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of ALBUTEIN 5% VIAL 250ML pharmaceutical products by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,954.40 firm fixed-price delivery order was awarded on December 20, 2024 by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics support to the U.S. military. The contract has an ultimate completion date of January 14, 2025 and was not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,137.50 Firm Fixed Price delivery order covers the supply of ALBUKED-25 VIAL 50ML medical products, with a period of performance through December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,320.60 firm-fixed-price delivery order is for medical supplies, specifically ALBUKED-5 VIAL 250ML, with a performance period running through February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,113.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of ALBUKED-25 VIAL 100ML, a pharmaceutical product, with a period of performance through January 8, 2025. The contract has a firm fixed price pricing type and was not set aside for any specific business category. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,140.75 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.20 firm fixed-price contract provides for the delivery of ALBUKED-25 VIAL 100ML medical supplies by November 27, 2024. This contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for the company...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The order, valued at $1,427.40, is for the supply of 250 mL vials of the pharmaceutical product ALBUTEIN 5%. The delivery order has a completion date of February 26, 2024 and was awarded on February 2, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA, valued...
This federal contract award is for the delivery of ALBUTEIN 25% VIAL 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,461.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 16, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 7, 2024. This contract is not associated with any set-aside designation....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFU10
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,354.20 firm fixed-price delivery order is for the supply of ALBUTEIN 5% VIAL 250ML, a medical product, with a performance period running through March 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 6/1/25, 3:36 AM